Profile
AEMD ABT BSX-PA BSX SYK MDT
Company Name Aethlon Medical, Inc. Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $6.00M $225.95B $175.45B $142.29B $139.39B $117.37B
Employees 0.01K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Mr. James B. Frakes M.B.A. Mr. Robert B. Ford Mr. Michael F. Mahoney Mr. Michael F. Mahoney Mr. Kevin A. Lobo Mr. Geoffrey Straub Martha
Ratings
AEMD ABT BSX-PA BSX SYK MDT
Quant Rating Score 3 4 3 3 3
Quant Rating Neutral Buy Neutral Neutral Neutral
Trading
AEMD ABT BSX-PA BSX SYK MDT
Last Close $0.415 $130.28 $122.18 $96.42 $363.84 $91.51
High 52 $1.76 $140.22 $122.18 $106.18 $399.9 $94.5
Low 52 $0.26 $100.07 $122.18 $66.04 $315.94 $76.84
Price vs. 52 Week High -76.42 % -7.09 % 0 % -9.19 % -9.02 % -3.16 %
Price vs. 52 Week Low 59.62 % 30.19 % 0 % 46 % 15.16 % 19.09 %
Total Return
AEMD ABT BSX-PA BSX SYK MDT
1 Month Return -34.25 % -1.15 % 0 % -9.16 % -6.32 % -0.75 %
3 Month Return 16.08 % 14.81 % 0 % 6.92 % -2.94 % 10.95 %
6 Month Return 8.07 % 11.92 % 0 % 15.74 % -1.73 % 1.68 %
9 Month Return -39.59 % 25.94 % 0 % 25.29 % 6.07 % 12.06 %
YTD Return -51.74 % 15.18 % 0 % 7.95 % 1.05 % 14.56 %
1 Year Return -75 % 8.42 % 0 % 46 % 1.95 % 7.56 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AEMD ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.72 % - - 0.89 % 3.05 %
Dividend Paid and Capex Coverage Ration (TTM) -2719.94 % 1.42 % 3.37 % 3.37 % 2.15 % 1.34 %
Dividend Per Share (TTM) - 2.24 % - - 3.24 % 2.79 %
Payout Ratio (TTM) - 28.62 % 1.24 % 1.24 % 40.73 % 84.62 %
Profitability
AEMD ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM - 55.59 % 67.02 % 67.02 % 62.84 % 62.89 %
Return on Assets TTM -0.15 % 16.46 % 4.7 % 4.7 % 6.97 % 4.73 %
Return on Equity TTM -0.88 % 32.37 % 8.94 % 8.94 % 15.02 % 8.69 %
Return on Capital Employed TTM -0.21 % 10.32 % 8.63 % 8.63 % 10.75 % 7.74 %
Net Income Per EBT TTM 100 % 191.1 % 81.07 % 81.07 % 85.71 % 81.56 %
EBT Per Ebit TTM 97.3 % 101.01 % 80.13 % 80.13 % 91.89 % 86.39 %
EBIT Per Revenue TTM - 16.55 % 17.01 % 17.01 % 16.82 % 18.21 %
Cash Flow To Debt Ratio TTM -824.37 % 56.97 % 30.82 % 30.82 % 31.2 % 27.41 %
Receivables Turnover TTM - 4.42 6.55 6.55 5.67 5.43
Payables Turnover TTM 0.28 4.44 5.75 5.75 5 5.39
Inventory Turnover TTM - 3.01 1.97 1.97 1.76 2.2
Fixed Asset Turnover TTM - 393.6 % 447.28 % 447.28 % 655.31 % 503.55 %
Asset Turnover TTM - 51.53 % 42.51 % 42.51 % 52.58 % 36.9 %
Operating Cash Flow Per Share TTM -427.97 4.94 2.33 2.33 11.13 5.69
Free Cash Flow Per Share TTM -428.13 3.67 1.66 1.66 9.15 4.26
Cash Per Share TTM 34560.2 % 460.07 % 28.12 % 28.12 % 1155.38 % 617.75 %
Operating Cash Flow Sales Ratio TTM - 20.4 % 20.51 % 20.51 % 18.77 % 21.97 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.04 % 74.21 % 70.98 % 70.98 % 82.2 % 74.96 %
Cash Flow Coverage Ratios TTM -824.37 % 56.97 % 30.82 % 30.82 % 31.2 % 27.41 %
Price To Free Cash Flows Ratio TTM - 35.58 56.98 58.37 39.97 21.47
Price To Operating Cash Flows Ratio TTM - 26.36 40.34 41.32 32.81 16.09
Price Cash Flow Ratio TTM - 26.36 40.34 41.32 32.81 16.09
Income Statement (TTM)
AEMD ABT BSX-PA BSX SYK MDT
Revenue $0B $41.95B $16.75B $16.75B $22.6B $32.36B
Gross Profit $-0B $23.24B $11.49B $11.49B $14.44B $21.15B
Gross Profit Ratio 0% 55.41% 68.61% 68.61% 63.91% 65.34%
EBITDA $-0.01B $10.83B $2.6B $2.6B $5.72B $8.2B
Net Income $-0.01B $13.4B $1.85B $1.85B $2.99B $3.68B
EPS Diluted -4.86 7.67 1.25 1.25 7.76 2.76
Balance Sheet (MRQ)
AEMD ABT BSX-PA BSX SYK MDT
Long Term Debt $0B $13.52B $8.97B $8.97B $0B $24.77B
Total Liabilities $0B $33.51B $17.39B $17.39B $22.34B $39.56B
Total Equity $0.01B $47.9B $22B $22B $20.63B $50.42B
Total Investments $0B $1.24B $0.56B $0.56B $0.75B $8.34B
Total Debt $0B $15.02B $10.75B $10.75B $1.41B $26.05B
Total Assets $0.01B $81.41B $39.4B $39.4B $42.97B $89.98B
Cash Flow Statement (TTM)
AEMD ABT BSX-PA BSX SYK MDT
Net Income $-0.01B $13.4B $1.85B $1.85B $2.99B $3.68B
Inventory $0B $-0.06B $-0.23B $-0.23B $0.05B $-0.14B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.67B
Operating Cash Flow $-0.01B $8.56B $3.44B $3.44B $4.24B $6.79B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.59B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 129.87
AFIB Acutus Medical, Inc. 0.042
AHCO AdaptHealth Corp. 9.61
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 160.43
ALUR Allurion Technologies Inc. 2.4125
AMIX Autonomix Medical, Inc. Common Stock 2.05
ANIK Anika Therapeutics, Inc. 15.2
AORT Artivion, Inc. 23.46
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 1.03
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 9.27
AVNS Avanos Medical, Inc. 14.465
AXDX Accelerate Diagnostics, Inc. 1.18
AXGN AxoGen, Inc. 17.19
AXNX Axonics, Inc. 70.98
AZYO Aziyo Biologics, Inc. 1.49
BBLG Bone Biologics Corporation 0.83
ETFs With Exposure to AEMD
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 120.27
VXF Vanguard Extended Market Index Fund 0 170.17
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 131.85
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 131.86
VEMPX Vanguard Extended Market Index InstlPlus 0 325.39
Unlock